United Commercial Bank PLC (UCB) recently signed an agreement with the global digital payment service provider Visa. Mohammad Shafiqur Rahman, head of retail business division at UCB, and Sabbir Ahmed ...
Yet another drugmaker has joined the off-label marketing club. UCB agreed to pay $34 million to resolve claims it marketed its epilepsy drug Keppra to treat headaches and pain, uses not approved by ...
Smyrna, Ga.-based UCB has pleaded guilty to the off-label promotion of its epilepsy drug Keppra and will pay more than $34 million to resolve criminal and civil liability, according to a news release ...
The maker of epilepsy treatment Keppra agreed Thursday to pay more than $34 million for marketing the medication to treat migraine headaches in violation of U.S. drug laws.The U.S. subsidiary of ...
United Commercial Bank Limited (UCB) on Tuesday signed an agreement with Chittagong Metropolitan Police (CMP) on e-trafficking prosecution and a fine payment system. As per the agreement, the payment ...
WASHINGTON, June 9 (Reuters) - The American unit of Belgian pharmaceutical company UCB SA pleaded guilty on Thursday and will pay $34.4 million to settle criminal and civil charges that it illegally ...
While it is always good to see a solid dividend yield, we should also consider whether the payment is feasible. Having distributed dividends for at least 10 years, United Community Banks has a long ...
WASHINGTON, April 29 (Reuters) - Schwarz Pharma Inc, a unit of Belgium's UCB SA , has agreed to pay $22 million to settle false claims allegations about reimbursements for unapproved drugs, the U.S.
SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc. announced today that it has earned a milestone payment related to its collaboration with UCB and the evaluation of UCB0599 for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results